These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25978083)

  • 1. Methylphenidate facilitates hypnotizability in adults with ADHD: a naturalistic cohort study.
    Lotan A; Bonne O; Abramowitz EG
    Int J Clin Exp Hypn; 2015; 63(3):294-308. PubMed ID: 25978083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
    Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of placebo response in adults with attention-deficit/hyperactivity disorder: data from 2 randomized trials of osmotic-release oral system methylphenidate.
    Buitelaar JK; Sobanski E; Stieglitz RD; Dejonckheere J; Waechter S; Schäuble B
    J Clin Psychiatry; 2012 Aug; 73(8):1097-102. PubMed ID: 22780962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of methylphenidate to intensive dialectical behaviour therapy for patients suffering from comorbid borderline personality disorder and ADHD: a naturalistic study.
    Prada P; Nicastro R; Zimmermann J; Hasler R; Aubry JM; Perroud N
    Atten Defic Hyperact Disord; 2015 Sep; 7(3):199-209. PubMed ID: 25634471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor skills of children newly diagnosed with Attention Deficit Hyperactivity Disorder prior to and following treatment with stimulant medication.
    Brossard-Racine M; Shevell M; Snider L; Bélanger SA; Majnemer A
    Res Dev Disabil; 2012; 33(6):2080-7. PubMed ID: 22796639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.
    Konstenius M; Jayaram-Lindström N; Beck O; Franck J
    Drug Alcohol Depend; 2010 Apr; 108(1-2):130-3. PubMed ID: 20015599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term relationship between methylphenidate and tobacco consumption and nicotine craving in adults with ADHD in a prospective cohort study.
    Bron TI; Bijlenga D; Kasander MV; Spuijbroek AT; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):542-54. PubMed ID: 22809706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate dependency revisited: understanding the effects of methylphenidate in children with attention deficit hyperactivity disorder.
    Teicher MH; Polcari A; Anderson CM; Andersen SL; Lowen SB; Navalta CP
    J Child Adolesc Psychopharmacol; 2003; 13(1):41-51. PubMed ID: 12804125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.
    Fredriksen M; Dahl AA; Martinsen EW; Klungsøyr O; Haavik J; Peleikis DE
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1873-84. PubMed ID: 25453480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for more than 3 years' duration of central stimulant treatment in adult attention-deficit/hyperactivity disorder: a retrospective, naturalistic study.
    Torgersen T; Gjervan B; Nordahl HM; Rasmussen K
    J Clin Psychopharmacol; 2012 Oct; 32(5):645-52. PubMed ID: 22926598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-acting methylphenidate in adults with attention deficit hyperactivity disorder: a study with paired-pulse transcranial magnetic stimulation.
    Schneider MK; Retz W; Gougleris G; Verhoeven WM; Tulen JH; Rösler M
    Neuropsychobiology; 2011; 64(4):195-201. PubMed ID: 21912187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate.
    Hammerness P; Joshi G; Doyle R; Georgiopoulos A; Geller D; Spencer T; Petty CR; Faraone SV; Biederman J
    J Pediatr; 2013 Jan; 162(1):22-7.e2. PubMed ID: 22878114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Treatment Outcome in Adult Male Prisoners With Attention-Deficit/Hyperactivity Disorder: Three-Year Naturalistic Follow-Up of a 52-Week Methylphenidate Trial.
    Ginsberg Y; Långström N; Larsson H; Lindefors N
    J Clin Psychopharmacol; 2015 Oct; 35(5):535-43. PubMed ID: 26284932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Davis M; Mikami AY; Singh H; Merkel RL; Burket R
    J Clin Psychopharmacol; 2012 Apr; 32(2):225-30. PubMed ID: 22367664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.
    Hechtman L; Abikoff H; Klein RG; Weiss G; Respitz C; Kouri J; Blum C; Greenfield B; Etcovitch J; Fleiss K; Pollack S
    J Am Acad Child Adolesc Psychiatry; 2004 Jul; 43(7):812-9. PubMed ID: 15213582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.